Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker.
Birmpilis AI, Paschalis A, Mourkakis A, Christodoulou P, Kostopoulos IV, Antimissari E, Terzoudi G, Georgakilas AG, Armpilia C, Papageorgis P, Kastritis E, Terpos E, Dimopoulos MA, Kalbacher H, Livaniou E, Christodoulou MI, Tsitsilonis OE. Birmpilis AI, et al. Cells. 2022 Apr 22;11(9):1415. doi: 10.3390/cells11091415. Cells. 2022. PMID: 35563721 Free PMC article. Review.
Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide.
Birmpilis AI, Karachaliou CE, Samara P, Ioannou K, Selemenakis P, Kostopoulos IV, Kavrochorianou N, Kalbacher H, Livaniou E, Haralambous S, Kotsinas A, Farzaneh F, Trougakos IP, Voelter W, Dimopoulos MA, Bamias A, Tsitsilonis O. Birmpilis AI, et al. Cancers (Basel). 2019 Nov 9;11(11):1764. doi: 10.3390/cancers11111764. Cancers (Basel). 2019. PMID: 31717548 Free PMC article.
Prothymosin α and its C-Terminal Immunoreactive Decapeptide Show No Evidence of Acute Toxicity: A Preliminary In Silico, In Vitro and In Vivo Investigation.
Birmpilis AI, Vitsos P, Kostopoulos IV, Williams L, Ioannou K, Samara P, Karachaliou CE, Voutsas IF, Alyfanti E, Angelis N, Gavalas NG, Gkraikou T, Kappa N, Klagkou E, Klimentzou P, Nikou S, Papaioannou NE, Skopeliti M, Toukli D, Dimopoulos MA, Bamias A, Livaniou E, Kalbacher H, Tsitsilonis OE, Voelter W. Birmpilis AI, et al. Curr Med Chem. 2022;29(42):6463-6478. doi: 10.2174/0929867328666211117093401. Curr Med Chem. 2022. PMID: 34789121
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients.
Kostopoulos IV, Kakalis A, Birmpilis A, Angelis N, Orologas-Stavrou N, Rousakis P, Panteli C, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Tsitsilonis O, Terpos E. Kostopoulos IV, et al. Am J Hematol. 2023 Mar;98(3):E65-E67. doi: 10.1002/ajh.26823. Epub 2022 Dec 30. Am J Hematol. 2023. PMID: 36565455 Free article. No abstract available.